The development of a novel PARP inhibitor with potent antitumor activity in various tumor xenograft models

被引：0
|
作者：
Park, Ji-Seon [1 ]
Kim, Jang-Hyun [1 ]
Cheon, Kwang-Woo [1 ]
Cho, Bo-Young [1 ]
Kim, Kang-Jeon [1 ]
Lee, Han-Chang [1 ]
Kim, Young-Cheol [1 ]
Oh, Hyung-Chan [1 ]
Lee, Hyun-Ho [1 ]
Kim, Jeong-Min [1 ]
机构：
[1] JEIL Pharm, Yongin, South Korea
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-825
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
825
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Novel, Selective Inhibitor of Fibroblast Growth Factor Receptors That Shows a Potent Broad Spectrum of Antitumor Activity in Several Tumor Xenograft Models
    Zhao, Genshi
    Li, Wei-ying
    Chen, Daohong
    Henry, James R.
    Li, Hong-Yu
    Chen, Zhaogen
    Zia-Ebrahimi, Mohammad
    Bloem, Laura
    Zhai, Yan
    Huss, Karen
    Peng, Sheng-bin
    McCann, Denis J.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (11) : 2200 - 2210
  • [2] A novel HDAC inhibitor, CKD-581 demonstrates a potent in vivo efficacy in various human tumor xenograft models
    Kim, Mi Jeong
    Lee, Chang Sik
    Han, Byeong Hoon
    Yang, Hyun-mo
    Lee, Kyung Joo
    Kim, Se-Mi
    Oh, Hyun Taek
    Lim, Ln-Taek
    Shin, Hyoju
    Bae, Daeil
    Kim, Dal-Hyun
    Lee, Sungsook
    Hong, Chung Ii
    CANCER RESEARCH, 2010, 70
  • [3] A novel, potent and selective inhibitor of Wee1 with robust antitumor activity in various cancer xenograph models
    Gavory, Gerald
    O'Dowd, Colin
    Burkamp, Frank
    Rountree, Shane
    Rozycka, Ewelina
    Boyd, Caroline
    Gorges, Beronia
    Burton, Stephanie
    Wilkinson, Andy
    Shepherd, Steven
    Janssen, Dominic
    McFarland, Mary
    Rountree, Shane
    Harrison, Tim
    CANCER RESEARCH, 2016, 76
  • [4] Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
    Wang, Yannick
    Wozniak, Agnieszka
    Wellens, Jasmien
    Gebreyohannes, Yemarshet K.
    Guillen, Maria Jose
    Aviles, Pablo M.
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    TRANSLATIONAL ONCOLOGY, 2020, 13 (11):
  • [5] BGB-283: a novel RAF Dimer inhibitor, displays potent antitumor activity in HCC patient derived xenograft models
    Tang, Zhiyu
    Liu, Yong
    Jiang, Beibei
    Gao, Yajuan
    Gong, Wenfeng
    Wang, Xing
    Su, Dan
    Yu, Fenglong
    Liu, Ye
    Wei, Min
    Wang, Lai
    CANCER RESEARCH, 2016, 76
  • [6] Preclinical antitumor activity of the MEK inhibitor R05068760 in human tumor xenograft models
    Brian, Higgins
    Kolinsky, Kenneth
    Daouti, Sherif
    Rizzo, Christine
    Wang, Huisheng
    Huby, Nicholas
    Niu, Huifeng
    Packman, Kathryn
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [7] Plocabulin, a novel tubulin inhibitor, has antitumor activity in various patient-derived xenograft models of soft tissue sarcoma
    Wang, Yannick
    Wozniak, Agnieszka
    Cornillie, Jasmien
    Lee, Che-Jui
    Guillen, Maria Jose
    Aviles, Pablo
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    CANCER RESEARCH, 2020, 80 (16)
  • [8] A Novel Eg5 Inhibitor (LY2523355) Causes Mitotic Arrest and Apoptosis in Cancer Cells and Shows Potent Antitumor Activity in Xenograft Tumor Models
    Ye, Xiang S.
    Fan, Li
    Van Horn, Robert D.
    Nakai, Ryuichiro
    Ohta, Yoshihisa
    Akinaga, Shiro
    Murakata, Chikara
    Yamashita, Yoshinori
    Yin, Tinggui
    Credille, Kelly M.
    Donoho, Gregory P.
    Merzoug, Farhana F.
    Li, Heng
    Aggarwal, Amit
    Blanchard, Kerry
    Westin, Eric H.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (11) : 2463 - 2472
  • [9] Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation
    Du, Mengyan
    Yu, Ting
    Zhan, Qinjinge
    Li, Han
    Zou, Yiping
    Geng, Meiyu
    Meng, Tao
    Xie, Zuoquan
    CANCER SCIENCE, 2022, 113 (09) : 2974 - 2985
  • [10] Antitumor activity of CUDC-305, a novel oral HSP90 inhibitor, in solid and hematological tumor xenograft models
    Bao, Rudi
    Lai, Cheng-Jung
    Qu, Hui
    Wang, Dagong
    Zifcak, Brian
    Yin, Lin
    Tao, Xu
    Zhai, Hai-Xiao
    Xu, Guang-Xin
    Atoyan, Ruzanna
    Samson, Maria
    Wang, Jing
    Forrester, Jeffrey
    DellaRocca, Steven
    Cai, Xiong
    Qian, Changgeng
    CANCER RESEARCH, 2009, 69
12345